ATRC - AtriCure, Inc.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 34.55

Open

$ 34.19

Bid

$ 30.36 x 1

Ask

$ 39.00 x 75

Day's Range

$ 33.76 - $ 35.13

52 Week Range

$ 28.29 - $ 43.11

Volume

730,658

Average Volume

Market Cap

1.72B

Beta (5Y Monthly)

$ 1.37

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-30-2025	09-30-2025	10-Q
2	07-30-2025	06-30-2025	10-Q
3	04-30-2025	03-31-2025	10-Q
4	02-14-2025	12-31-2024	10-K
5	10-30-2024	09-30-2024	10-Q
6	07-31-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-16-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	07-26-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-22-2023	12-31-2022	10-K
13	11-02-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-17-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	04-28-2021	03-31-2021	10-Q
20	02-26-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	07-29-2020	06-30-2020	10-Q
23	04-30-2020	03-31-2020	10-Q
24	02-24-2020	12-31-2019	10-K
25	10-31-2019	09-30-2019	10-Q
26	07-31-2019	06-30-2019	10-Q
27	04-26-2019	03-31-2019	10-Q
28	03-01-2019	12-31-2018	10-K
29	11-02-2018	09-30-2018	10-Q
30	08-02-2018	06-30-2018	10-Q
31	04-27-2018	03-31-2018	10-Q
32	02-28-2018	12-31-2017	10-K
33	11-02-2017	09-30-2017	10-Q
34	07-28-2017	06-30-2017	10-Q
35	05-05-2017	03-31-2017	10-Q
36	03-08-2017	12-31-2016	10-K
37	10-28-2016	09-30-2016	10-Q
38	08-05-2016	06-30-2016	10-Q
39	04-29-2016	03-31-2016	10-Q
40	02-29-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on AtriCur...
10/30/2025 13:27:58

Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $53 ...

AtriCure Raises FY2025 Adj EPS Guidance fr...
10/29/2025 20:02:24

AtriCure (NASDAQ:ATRC) raises FY2025 Adj EPS guidance from $(0.39)-$(0.34) to $(0.26)-$(0.23) vs $(0.49) analyst estimate. Rais...

AtriCure Q3 Adj. EPS $(0.01) Beats $(0.12)...
10/29/2025 20:01:20

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.12) by 9...

Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

AtriCure Enrolls, Treats First Patient In ...
10/28/2025 12:08:38

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left at...

Needham Maintains Buy on AtriCure, Raises ...
07/30/2025 10:44:15

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $44 to $45.

why-lendingclub-shares-are-trading-higher-by-around-23-here-are-20-stocks-moving-premarket

Why LendingClub Shares Are Trading Higher ...
07/30/2025 09:41:46

12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 21:06:19

AtriCure Raises FY2025 Adj EPS Guidance fr...
07/29/2025 20:05:51

AtriCure (NASDAQ:ATRC) raises FY2025 Adj EPS guidance from $(0.55)-$(0.50) to $(0.39)-$(0.34) vs $(0.53) analyst estimate. Rais...

AtriCure Q2 Adj. EPS $(0.02) Beats $(0.17)...
07/29/2025 20:04:03

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.17) by 8...

Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

AtriCure Completes Enrollment In Left Atri...
07/15/2025 12:05:21

Largest cardiac surgery device trial ever with 6,500 patients enrolled, this landmark trial evaluates the stroke reduction bene...

UBS Maintains Buy on AtriCure, Lowers Pric...
04/30/2025 14:21:00

UBS analyst Danielle Antalffy maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $60 to $58.

JMP Securities Reiterates Market Outperfor...
04/30/2025 14:18:35

JMP Securities analyst Daniel Stauder reiterates AtriCure (NASDAQ:ATRC) with a Market Outperform and maintains $60 price tar...

14 Analysts Assess AtriCure: What You Need...
04/30/2025 13:01:14

visa-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-wednesday

Visa To Rally More Than 12%? Here Are 10 T...
04/30/2025 11:37:48

Needham Maintains Buy on AtriCure, Lowers ...
04/30/2025 10:45:28

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $51 to $44.

AtriCure Raises FY2025 Adj EPS Guidance fr...
04/29/2025 20:08:43

AtriCure (NASDAQ:ATRC) raises FY2025 Adj EPS guidance from $(0.64)-$(0.57) to $(0.55)-$(0.50) vs $(0.66) analyst estimate. Affi...

AtriCure Q1 Adj. EPS $(0.14) Beats $(0.23)...
04/29/2025 20:02:38

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.23) by 3...

Earnings Scheduled For April 29, 2025
04/29/2025 08:32:27